Profil
Leena Gandhi is currently the Director at Bright Peak Therapeutics, Inc. and the Chief Medical Officer at Nextpoint Therapeutics, Inc. She previously worked as an Independent Non-Executive Director at NexImmune, Inc. from 2022 to 2024, as the Director-Cancer Therapeutic Innovation at Dana-Farber Cancer Institute, Inc. from 2020 to 2023, as the Director-Thoracic Medical Oncology at New York University from 2016 to 2018, and as the Vice President-Immuno Oncology Development at Eli Lilly & Co. from 2018 to 2020.
Dr. Gandhi received her undergraduate degree from the University of Utah, her graduate degree from New York University in 2002, and her doctorate degree from the University of California, Berkeley in 1998.
Postes actifs de Leena Gandhi
| Sociétés | Poste | Début |
|---|---|---|
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for the treatment of cancer and autoimmune diseases | Directeur/Membre du Conseil | 28/02/2022 |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates life sciences research and development company | Directeur Technique/Scientifique/R&D | 01/01/2023 |
Anciens postes connus de Leena Gandhi
| Sociétés | Poste | Fin |
|---|---|---|
| NEXIMMUNE, INC. | Directeur/Membre du Conseil | 27/08/2024 |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Corporate Officer/Principal | 01/01/2023 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/05/2020 |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/06/2018 |
Formation de Leena Gandhi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
NexImmune, Inc.
NexImmune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops T cell immunotherapies | Health Technology |
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Provides treatment to cancer patients | Health Services |
University of Utah
University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nextpoint Therapeutics, Inc.
Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates life sciences research and development company | Commercial Services |
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
















